Formulation of betacyclodextrin based nanosponges of itraconazole

被引:122
作者
Swaminathan, Shankar
Vavia, P. R. [1 ]
Trotta, Francesco
Torne, Satyen
机构
[1] Mumbai Univ, Inst Chem Technol, Pharmaceut Div, Bombay 400019, Maharashtra, India
[2] Univ Turin, Dept Chem IFM, I-10125 Turin, Italy
关键词
betacyclodextrins; nanosponges; itraconazole;
D O I
10.1007/s10847-006-9216-9
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Nanosponges are betacyclodextrins crosslinked with carbonate bonds. The polymer formed is nanoparticulate in nature. Itraconazole is a BCS Class II drug that has a dissolution rate limited poor bioavailability. Rationale of the work was to enhance the solubility of Itraconazole so that the bioavailability problems are solved. Solid dispersion technique has been used for drug incorporation. The effect of a ternary component copolyvidonum on solubility of itraconazole has been studied. Phase solubility studies has been carried out with a rationale of comparing the solubilization efficiency of nanosponges, copolyvidonum and combination. The dispersions were characterized by differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD) and photon correlation spectroscopy (PCS). It was found that the solubility of itraconazole was enhanced more than 50-folds with a ternary solid dispersion system. Using copolyvidonum in conjunction with nanosponges helps to increase the solubilization efficiency of nanosponges as evident from the phase solubility studies.
引用
收藏
页码:89 / 94
页数:6
相关论文
共 11 条
[1]  
[Anonymous], [No title captured], Patent No. [WO03/085002 A1, 03085002]
[2]   The stability of cyclodextrin complexes in solution [J].
Connors, KA .
CHEMICAL REVIEWS, 1997, 97 (05) :1325-1357
[3]   Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban:: Formation of aggregates and higher-order complexes [J].
Duan, MS ;
Zhao, N ;
Össurardóttir, IB ;
Thorsteinsson, T ;
Loftsson, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 297 (1-2) :213-222
[4]  
Higuchi T., 1965, Interscience, New York, V4, P117
[5]   Pharmaceutical applications of cyclodextrins .1. Drug solubilization and stabilization [J].
Loftsson, T ;
Brewster, ME .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (10) :1017-1025
[6]   Effect of hydrophilic polymer on solubilization of fenofibrate by cyclodextrin complexation [J].
Patel, A. R. ;
Vavia, P. R. .
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2006, 56 (1-2) :247-251
[7]   Characterization of the Interaction of 2-hydroxypropyl-β-cyclodextrin with itraconazole at pH 2, 4, and 7 [J].
Peeters, J ;
Neeskens, P ;
Tollenaere, JP ;
Van Remoortere, P ;
Brewster, ME .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (06) :1414-1422
[8]   Itraconazole formulation studies of the melt-extrusion process with mixture design [J].
Rambali, B ;
Verreck, G ;
Baert, L ;
Massart, DL .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2003, 29 (06) :641-652
[9]   Complexation thermodynamics of cyclodextrins [J].
Rekharsky, MV ;
Inoue, Y .
CHEMICAL REVIEWS, 1998, 98 (05) :1875-1917
[10]   Characterization of chitosan hydrochloride-mucin interaction by means of viscosimetric and turbidimetric measurements [J].
Rossi, S ;
Ferrari, F ;
Bonferoni, MC ;
Caramella, C .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 10 (04) :251-257